Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Evestra Onkologia awarded grant to support endometriosis drug development

Jan. 25, 2017

Crinetics Pharmaceuticals discloses novel somatostatin sst2 receptor agonists

Jan. 24, 2017

NeuroVive signs preclinical collaboration agreement with CHOP for mitochondrial disorders

Jan. 23, 2017

REGN-2477 receives FDA orphan designation for fibrodysplasia ossificans progressiva

Jan. 23, 2017

Suliqua approved in Europe for type 2 diabetes

Jan. 20, 2017

EMA awards orphan designation to Abeona Therapeutics' ABO-101

Jan. 20, 2017

Lilly identifies novel MetAP2 and DPP IV inhibitors

Jan. 20, 2017

Novo Nordisk initiates first human dose trial of NNC0194-0499

Jan. 20, 2017

Academia Sinica discloses new glucagon-like peptide 1 modulators

Jan. 19, 2017

Exelixis discovers new S1P1 and S1P5 receptor agonists

Jan. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026